Clinical Trials Arena on MSN
Biohaven reports Phase II BHV-7000 trial results for MDD
Overall tolerability and safety were observed, with adverse events primarily mild or moderate and resolving spontaneously.
Characteristics of Patients and Prognostic Factors Across Treatment Lines in Metastatic Colorectal Cancer: An Analysis From the Aide et Recherche en Cancérologie Digestive Database A safety cohort ...
Zipalertinib in Patients With Epidermal Growth Factor Receptor Exon 20 Insertion-Positive Non–Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy With or Without Amivantamab ...
A multicenter team including Endeavor Health and Eli Lilly found that once-weekly eloralintide produced dose-dependent weight loss up to 20% over 48 weeks in adults with obesity or overweight without ...
Cynata Therapeutics has achieved a major catalyst for 2025 by completing patient enrolment in its Phase II clinical trial of ...
Chennai Metro Rail Limited (CMRL) is preparing to introduce frequent peak-hour services on the Poonamallee–Porur stretch of ...
Despite falling short of its primary Phase II objective, Nektar plans to push its T cell stimulator rezpeg into Phase III ...
With what Insmed calls an "outstanding" phase 2 win for its treprostinil palmitil inhalation powder (TPIP) in patients with pulmonary arterial hypertension (PAH), the company is racing to phase 3 as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results